je.st
news
Biotech Weekly: The NASDAQ Sub $10 Million Market Cap Club
2016-01-26 11:25:04| Biotech - Topix.net
Reasons to review the NASDAQ sub $10 million market cap list include the value of a NASDAQ listing, significant remaining assets, overly negative sentiment, and ignored upside scenarios. Current sub $10 million market cap NASDAQ biotechs include Cellectar Biosciences, Nanosphere, Lpath, Signal Genetics, Venaxis, TetraLogic Pharmaceuticals, Eleven Biotherapeutics, and GenVec.
Tags: club
market
million
weekly
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||